Leading Change: Building Our Future Growth Together

On January 1, 2026, Novo Nordisk Israel enters its new chapter with a clear ambition: To Play to Win in Cardiometabolic care. We are evolving from a structure built around separate Diabetes and Obesity business units to one integrated, customer-centric Cardiometabolic structure. This is a strategic choice about where we play and how we win!

To explore and better understand what’s behind this decision, we sat down with the Change Team: Galit (GKZ), Keren (KNBK), Geula (GZGE), Einav (ENAC) and Michal (HCMS) for an open conversation on the strategic intent, expectations and opportunities this change creates for all of us.

Galit: “Focus, Clarity and Impact. Patients and HCPs don’t experience Cardiometabolic disease in silos, yet we were still organized that way. Applying a play to win lens, it became clear that to lead in the future and win competition we must simplify and integrate - including speaking about Wegovy and Ozempic as one coherent portfolio.

This shift allows us to reduce overlap between Obesity and Diabetes, show up to HCPs with one consistent narrative and focus on the full Cardiometabolic journey rather than fragmented conversations.

Its not a change for the sake of change - it’s a strategic move from strength, designed to sharpen focus, improve execution, help us win together and lead the Cardiometabolic care in Israel with meaningful impact on patients”.

Geula - Cardio-Metabolic Sales Director: “The new Sales unit spearheads portfolio sales. Our reps no longer compete internally. We’re one team with one goal - to lead and maintain market leadership.”

Einav - Cardio-Metabolic Marketing Director: “The Marketing unit focuses on building the best strategy for our products based on market conditions - customers, competitors, access and creating materials, messages, and tools for the Sales Teams. We aim to bring innovation so that ultimately the customers choose our products because of the added value for them and their patients.”

Einav: “The big difference is focusing on customers rather than products. Customer Teams will work together under a shared strategy, with built-in synchronization between functions, while remaining efficient and avoiding unnecessary meetings. The challenge is good integration and effective cross-functional work, and it’s up to us - Geula, myself and Michal - to make it happen”.

Michal: “The new structure streamlines interfaces between Medical and Commercial and allows for deeper engagement with internal partners. Everyone will have their ‘go-to person’. This applies to both Medical Advisors and MSLs, who will be aligned geographically with the reps”.

Geula: “In the new structure, all functions will support sales. We have the best products for Diabetes and Obesity: we’re at the forefront in terms of accumulated experience and robust research data. The goal is to speak with one voice, reach more physicians, and demonstrate the value we can deliver to patients.”

Keren: “Change brings opportunities - to learn new products, develop new relationships internally and with HCPs, strengthen our professionalism, and create impact. In designing this process, the Change Team thought about each of our employees: we considered the role that fits each person, personal career aspirations, constraints, strengths, and areas for development. We succeeded in placing all employees in roles we truly believe will benefit them and the organization.

The important thing to remember that the end goal is to reach more physicians and more patients. Therefore, it’s essential that each of us embraces the change and does everything possible to achieve our business objectives”.

Keren: “I truly believe that change keeps us relevant and drives evolution - both individually and as an organization. Embracing a mindset of continuously challenging the status quo is key. When each of us focuses on the positive and gives our very best, we can achieve remarkable results.”

Geula: “My personal motto is to believe in my abilities and those of the people I work with - to adapt, overcome tough moments, and succeed. With the right perspective and willingness to invest, we can do new and amazing things.”

Michal: “Discomfort in change is natural, and I try not to dwell on what I lost, but on the advantages and opportunities the change enables. If I take inspiration from running, stopping and starting again requires much more energy than slowing down a bit and continuing. For me, it’s important to stay in motion, even if not everything is certain.”

Einav: “I believe every change is an opportunity. There’s something exciting about new things - even if it’s hard. It activates your mind, makes you creative, and pushes you to find solutions.”

Galit: “My motto is simple: Embrace change as a chance to play bolder and win smarter. Every shift is an opportunity to align as one team, focus on what matters and turn challenges into our next big win”

Galit: “The clarity this change brings. We move from multiple voices and overlapping conversations to one clear consistent voice - especially around our GLP1 portfolio. For our customers and HCPs this means simplicity, coherence and trust. And for us - a shared purpose and a clear way to win together.”

Keren: “What excites me most is seeing an idea turn into reality and witnessing the value it brings - how it impacts both people and the organization. I look forward to watching our employees seize new opportunities, grow, and progress toward their goals, all while embracing different ways of working.”

Einav: “The focus on the customer. It’s not just a slogan, it’s very authentic. I’m also excited to have amazing people in the unit, half of whom I haven’t managed directly until now. It’s a bit hard to part from people moving to Sales, but I know I’m passing them to the best hands, and I appreciate how they embraced the change.”

Michal: “For me personally - returning to areas where Medical meets Commercial brings me closer to the ‘doing’ of Medical. Also, in this change, there’s an opportunity to focus on Medical Field Teams with the addition of Shani, who will lead the team, and the joint work with CEx to maximize their impact in the field.”

Geula: “It’s exciting to see the potential. The unknown is the exciting part - things we haven’t done, haven’t tried, that are just around the corner waiting to be discovered. It’s exciting to work with strong people and feel great pride in the company.”

Galit: “Internally, success looks like high engagement, strong collaboration and clear accountability. Less overlap, faster decisions and sharper execution. Externally we are, OF COURSE, winning in the market and making a difference for thousands of patients that rely on us every day”.

Einav: “Success is being market leaders with both products, reaching and exceeding our targets, and leaving a mark among physicians and patients as those who brought something new and different. In a year, I see us as a unit working hand-in-hand with Sales, Medical, MAPA, CEx and all supporting functions - like an orchestra - where we all succeed together.”

Geula: “Without a doubt - maintaining market leadership. We’re among the few countries still leading against our competitor in both diabetes and obesity, and we need to keep doing that. Also internally - climbing into Novo’s top ten in sales!”

Michal: “Success to me would be the feeling among our people across all units that after the transition period, they’ll say we’re working smarter, we achieved our goals, and it was worth it-the right step to take.”

Keren: “Success, one year from now, means we’ve achieved the business goals and secured a position - both as an organization that makes a real impact on patients and as an employer of choice. A place where the best people want to stay and where the best talent aspires to join.”